Abstract: 3-Substituted 1,2,4-triazole derivatives (5, 9, 13, 16b, 19), pyrimidinium salts (21), triazines (24), and aryl methylene hydrazono pyrazolopyrano-pyrimidine ( 27a,b) which are rearranged in basic medium to 30a,b, were afforded via the reaction of 6-amino 1,4,5,6-tetrahydro-5-imino-3-methyl-1-phenyl-4 (pchlorophenyl) pyrazolo [4', 3' : 5,6]-pyrano [2,3-d] pyrimidine (3) with different reagents.
Introduction
Condensed pyrazoles are biologically interesting compounds and their chemistry has received considerable attention [1, 2] . Several pyrano [2,3-c] pyrazoles are reported to have useful biological effects, such as analgesic and anti-inflammatory activities [3] . Moreover, the biological activity of fused azoles has led to intensive research on their synthesis [4] [5] [6] .
Results and Discussion
In the present study, we report on the synthesis of pyrazolo [4`, 3` : 5,6] pyrano [3,2- Compound 3, considered as a key intermediate to prepare fused heterocycles as triazolo [1,5-c] pyrimidines which may possess pharmacological properties similar to theophylline [7, 8] , was prepared by treating ethyl N-(5-cyano-1,4-dihydro-3-methyl-1-phenyl-4-(p-chlorophenyl)-pyrano- [2,3-c] pyrazol-6-yl-methan-imidate (2) with hydrazine hydrate [9, 10] . On the other hand, compound 2 was prepared by the reaction of 6-amino-5-cyano-1,4-dihydro-3-methyl-1-phenyl-4 (p-chlorophenyl) pyrano [2,3-c] pyrazole (1) [11, 12] with an equimolar amount of triethyl orthoformate and acetic anhydride [9, 10] [1,5- c] pyrimidine (9) was produced. Compound 9 was also produced via the reaction of 3 with acetic anhydride (10) as carboxylic acid anhydride and acetyl chloride (11) as acid chloride. The structure of 9 was based on the absence of NH and NH 2 absorption in the i.r. spectrum. (Scheme 2).
Moreover, the interaction of triethylorthopropionate (12) with 3 afforded 3-ethyl -10-methyl-8,11-dihydro-11- The subsequent incorporation of a one-carbon unit carrying an amino group into 3 to form the triazolo component was performed via two facile procedures. The first one consisted in applying cyanogen bromide (14) condensation to compound 3 and the second one involved refluxing the compound 3 and S-methyl isothiourea sulfate (15) [13] to afford 3-amino-10-methyl-8,11
.That compound 16b exists in the 2-amino tautomeric form and not in the 2-iminoform was shown by the appearance of an intense absorption band at 3400 cm -1 and a two proton singlet as broad band at 3.7 ppm due to NH 2 in the i.r. and 1H nmr spectra respectively. In the case involving the condensation of compound 3 with cyanogen bromide (14) and S-methyl isothiourea sulfate (15) , the intermediates formed might bear a cyanimino (17) or guanidino function (18) . These intermediates (17 and 18) were cyclized ) in an alkaline medium to give the target molecule 16b as expected (Scheme 2). However because of the different electronic influence on each reaction centre, 16b was obtained in different yields.
The formation of 3-trichloromethyl-10-methyl-8,11-dihydro-11-(p-chlorophenyl)-8-phenyl pyrazolo [4`, 3` : 5,6] (20) in the absence of solvent under reflux according to a reported procedure for the construction of an allied heterocyclic system [14] was unsuccessful (Scheme 3). The pyrimidinium salt (21) was formed [15,16a,b] , based on the presence of NH and NH2 in its i.r. spectrum and the appearance of CN, its mass spectrum was (M + -NH 2 , 532.2, 30%). The trichloro methyl derivatives (19) were achieved using trichloroacetic acid (22) in the presence of phosphoryl chloride under reflux for 3 hours. The structure (19) was confirmed by the absence of NH and NH 2 absorption in its i.r. spectrum.
The activity of compound 3 towards the reaction product was active methylene was also tested [17] . Thus, with ethyl cyanoacetate (23), 9,12-dihydro-3-hydroxy-11- [18] . Also the same product (27b) was isolated from the reaction of compound 3 with ptolulaldehyde and p-anisaldehyde 29a,b respectively. Based on their spectral data no cyclization took place (Scheme 3). From this experiment, it can be concluded that a Taylor-Löeffler transformation has occured [9] . Because the reaction was carried out in basic medium as catalyst which facilitates the Dimorth rearrangement, the formal structure 30a,b is preferable (Scheme 3).
For convenience of the readers, the spectroscopic data are also collected in Table 1 . 
Experimental

General
Melting points are uncorrected and were taken on a Boetius melting point microscope. Microanalyses were performed by the Micro-analytical unit Cairo University I.R. spectra were recorded on a Mattson 5000 FIR spectrometer 1 H NMR spectra were determined on a Varian EM NMR spectrometer using tetra-methylsilan as an internal standand. Mass spectra (MS) were recorded on a Finigan SSQ 7000 mass spectrometer. 
Ethyl N-(5-cyano-1,4-dihydro-3-methyl-1-phenyl-4-(pchlorophenyl) pyrano[2,3-c] [pyrazol -6-yl] methanimidate (2):
6-Amino-1,4,5,6-tetrahydro-5-imino-3-methyl-1-phenyl-4-(p-chlorophenyl) pyrazolo [4`,3`, :5,6] pyrano [2,3-d] pyrimidine (3).
To a solution of 2 (2g, 0.005 mol) in methanol (25 ml) a solution of hydrazine hydrate (5 ml) was added and the mixture stirred for 1 hr. Then it is allowed to stand overnight. The precipitate formed is filtered, dried and crystallized from methanol to afford. 55% of 3. M.p. 
8,11-Dihydro-10-methyl-8-phenyl-4-(p-chlorophenyl) pyrazolo [4`,3`: 5,6] pyrano [3,2-e] [1,2,4] triazolo [1,5-c] pyrimidine (5).
Method A A mixture of 3 (1.01g, 0.0025 mol) and (32 ml, 0.7 mol) of formic acid 4 was refluxed for 10 hrs. and then cooled poured onto ice-water to give a white precipitate which was filtered, washed several times by water, dried. and then crystallized from ethanol to afford 55% of 5. M.p. 324-325°C. 1 
Method C
To a solution of 3 (1.01g, 0.0025 mol) in absolute ethanol (30 ml) was added ethoxymethylene malononitrile 7 and the mixture was refluxed for 6 hr (TLC control). On cooling, a solid product separated, which was filtered and recrystallized from ethanol to give 0.85g (82%) of 5.
3,10-dimethyl-8,11-dihydro-11-(p-chlorophenyl)-8-phenyl
pyrazolo [4`,3`,: 5,6] pyrano [3,2-e] [1,2,4,] triazolo [1,5-c] pyrimidine (9) Method A A solution of 3 (1.01g, 0.0025 mol) and (3.3g 0.2 mol) of triethylorthoacetate (8) 
Method B
A solution of 3 (1.01g, .0025 mol) and 10 ml of acetic anhydride (10) was refluxed for 10 hrs. A precipitate was formed, filtered while hot, and recrystallized from ethanol to give 0.8g (75%) of 9.
Method C A mixture of 3 (1.01g, 0.0025 mol) and 7 ml of acetyl chloride (11) in 10 ml dimethylformamide was heated for 4 hrs on a water bath and after cooling, poured into 100 ml of ice water. The precipitate was collected on a filter, washed with water and recrystallized from ethanol to give 0.9g (84%) of 9. [4`,3`:5,6 ]-pyrano [3,2-e] [1, 2, 4] triazolo [1,5-c] 
3-Ethyl 10-methyl-8,11-dihydro-11-(p-chlorophenyl)-8-phenyl pyrazolo
pyrimidine (13).
A solution of 3 (1.01 g, 0.0025 mol) and (3.4 g, 0.02 mol) of triethy-lor-thopropionate 12 neat was refluxed for 8 hrs, and then worked out as described above to produce 0.83 g (75%) of 13. M.p. 310-312°C. 
(NH)
Method A A solution of 3 (1.01 g, 0.0025 mol) in 50 ml dimethylformamide was kept at 0°C and treated with cyanogen bromide 14 (0.6 g, 0.005 mol). The mixture was refluxed for 5 hrs, then cooled and poured onto water to give a white precipitate, filtered, washed with water and crystallized from dimethylformamide to yield 0.54 g (50%) of 16b. M.p.>300 C. 1 
Method B
A solution of 3 (1.01 g, 0.0025 mol) and (0.28 g, 0.001 mol) of S-methylisothiourea sulfate 15 in alcoholic potassium hydroxide (0.5 N) was heated under reflux for 8 hours. After cooling, the mixture was poured on to water to give a white precipitate, which was collected, washed with water and recrystallized from dimethylformamide to yield 0.6 g (60%) of 16b. [4`,3`:5.6] pyrano [3,2-e] [1, 2, 4] triazolo [1,5 -c] pyrimidine (19) 
3-trichloromethyl-8,11-dihydro-11-(p-chlorophenyl)-8-phenyl pyrazolo
